(Q81380006)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15700118%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

title

Inhibition of HER-2 by three independent targeting strategies increases paclitaxel resistance of SKOV-3 ovarian carcinoma cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15700118%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference

1 reference

Shaker Abuharbeid

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15700118%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Jürgen Apel

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15700118%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Gerhard Zugmaier

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15700118%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Cornelius Knabbe

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15700118%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Martin Sander

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15700118%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Sandra Gilbert

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15700118%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Frank Czubayko

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15700118%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Achim Aigner

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15700118%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

publication date

8 February 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15700118%20AND%20SRC:MED&resulttype=core&format=json

Naunyn-Schmiedeberg's Archives of Pharmacology

8 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15700118%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

volume

371

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15700118%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15700118%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

page(s)

141-151

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15700118%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00210-004-1016-4

8 January 2020

exact match

0 references

cites work

Chemosensitization of HER-2/neu-overexpressing human breast cancer cells to paclitaxel (Taxol) by adenovirus type 5 E1A.

1 reference

12 December 2020

Recombinant humanized anti-HER2 antibody (Herceptin) enhances the antitumor activity of paclitaxel and doxorubicin against HER2/neu overexpressing human breast cancer xenografts

1 reference

12 December 2020

c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer

1 reference

12 December 2020

The effect of HER-2/neu overexpression on chemotherapeutic drug sensitivity in human breast and ovarian cancer cells

1 reference

12 December 2020

Apoptosis as a measure of chemosensitivity to cisplatin and taxol therapy in ovarian cancer cell lines

1 reference

12 December 2020

Growth regulation of human breast and ovarian tumor cells by heregulin: Evidence for the requirement of ErbB2 as a critical component in mediating heregulin responsiveness.

1 reference

12 December 2020

Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study Group.

1 reference

12 December 2020

Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancer

1 reference

12 December 2020

Role of erbB2 in breast cancer chemosensitivity

1 reference

12 December 2020

Taxanes propagate apoptosis via two cell populations with distinctive cytological and molecular traits

1 reference

12 December 2020

ERbB-2 expression is rate-limiting for epidermal growth factor-mediated stimulation of ovarian cancer cell proliferation

1 reference

12 December 2020

Trastuzumab: a review of its use in the treatment of metastatic breast cancer overexpressing HER2.

1 reference

12 December 2020

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

1 reference

12 December 2020

Adenovirus-mediated transduction of ribozymes abrogates HER-2/neu and pleiotrophin expression and inhibits tumor cell proliferation

1 reference

12 December 2020

Inducible antisense inhibition of erbB-2 expression reduces anchorage independent growth of ovarian carcinoma cells

1 reference

12 December 2020

Molecular description of evolving paclitaxel resistance in the SKOV-3 human ovarian carcinoma cell line

1 reference

12 December 2020

Role of Bcl-2 and its post-transcriptional modification in response to antitumor therapy.

1 reference

12 December 2020

The outcome of heregulin-induced activation of ovarian cancer cells depends on the relative levels of HER-2 and HER-3 expression

1 reference

12 December 2020

Reversal of HER-2 over-expression renders human ovarian cancer cells highly resistant to taxol

1 reference

12 December 2020

Evaluation of monoclonal humanized anti-HER2 antibody, trastuzumab, in patients with recurrent or refractory ovarian or primary peritoneal carcinoma with overexpression of HER2: a phase II trial of the Gynecologic Oncology Group

1 reference

12 December 2020

The role of HER-2 oncoprotein in drug-sensitivity in breast cancer (review).

1 reference

12 December 2020

Features of apoptotic cells measured by flow cytometry

1 reference

12 December 2020

E1A-mediated paclitaxel sensitization in HER-2/neu-overexpressing ovarian cancer SKOV3.ip1 through apoptosis involving the caspase-3 pathway.

1 reference

12 December 2020

Discovery of differentially expressed genes associated with paclitaxel resistance using cDNA array technology: analysis of interleukin (IL) 6, IL-8, and monocyte chemotactic protein 1 in the paclitaxel-resistant phenotype.

1 reference

12 December 2020

Reversible tumorigenesis in mice by conditional expression of the HER2/c-erbB2 receptor tyrosine kinase.

1 reference

12 December 2020

Increased expression of the putative growth factor receptor p185HER2 causes transformation and tumorigenesis of NIH 3T3 cells

1 reference

12 December 2020

The role of ErbB-2 tyrosine kinase receptor in cellular intrinsic chemoresistance: mechanisms and implications

1 reference

12 December 2020

Down-regulation of HER2/neu expression induces apoptosis in human cancer cells that overexpress HER2/neu

1 reference

12 December 2020

Adenovirus E1A expression enhances the sensitivity of an ovarian cancer cell line to multiple cytotoxic agents through an apoptotic mechanism

1 reference

12 December 2020

Epidermal growth factor-related peptides and their receptors in human malignancies

1 reference

12 December 2020

Overexpression of ErbB2 blocks Taxol-induced apoptosis by upregulation of p21Cip1, which inhibits p34Cdc2 kinase

1 reference

12 December 2020